
New TAU breakthrough may significantly improve breast cancer treatment
A new treatment developed at Tel Aviv University (TAU) may significantly enhance the efficacy of chemotherapy in breast cancer patients, reducing the risk for lung metastasis following chemotherapy from 52% to only 6%. The study, conducted in an animal model, identified the mechanism that generates a cancer-promoting inflammatory environment in response to chemotherapy. Moreover, the… Read More